All News

For patients with attention-deficit/hyperactivity disorder (ADHD), getting and staying organized and maintaining focus on the right things at the right time is a challenge. Some solutions are touted at the start of every year in the form of “getting organized” with the latest planners, smartphones as well as smart home devices like Amazon’s Alexa and Google Home.

E-cigarette smokers have a high risk of developing lung and bladder cancer, as well as certain heart diseases due to carcinogenic e-cigarette smoke (ECS), according to a study published in the Proceedings of the National Academy of Sciences.

One in every 4 drugs approved by the FDA over the past 4 years was a personalized medicine, and the agency approved a record-breaking 16 personalized therapies in the past year, according to a new report from the multi-stakeholder group the Personalized Medicine Coalition.

While the wholesale acquisition cost of the hemophilia A drug is approximately $482,000 for the first year of treatment and $448,000 for subsequent years, a draft report found that the drug would reduce the budget by approximately $1.85 billion per patient annually for patients aged 12 and older. In patents aged 12 and younger, emicizumab at wholesale acquisition cost pricing would reduce the budget by approximately $720,000 per patient annually.

Chimeric antigen receptor (CAR) T-cell therapy has been named the Advance of the Year in ASCO’s Clinical Cancer Advances 2018. According to the annual report, CAR T-cell therapy is “poised to transform the outlook for children and adults with certain otherwise incurable cancers."

Will healthcare become the ultimate employee discount for US workers of Amazon, JPMorgan Chase, and multinational conglomerate Berkshire Hathaway? Or something bigger for all Americans? The 3 disparate companies announced they will form a separate, independent company “free from profit-making incentives and constraints” to tackle the vexing problem of rising healthcare costs for employees and their families.

Officials at Omada Health said the PREDICTS trial was planned long before CMS decided not to include virtual providers in this spring's launch of the Medicare Diabetes Prevention Program. But a spokesperson said the company hopes the growing body of evidence in support of virtual programs will "assuage any concerns."

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text